UK Research and Innovation
VC Fund
Swindon, United Kingdom
UK Research and Innovation is a VC fund in Swindon focused on Biotechnology and Health Care. UKRI intends to be an outstanding organisation that ensures the UK maintains its world leading position in research and innovation.
- Total investments:
- 107
- Last investment:
- Lead investor:
- 81%
Last updated:
For AI agents: llms.txt
Industries UK Research and Innovation invests in
Stages UK Research and Innovation invests in
Countries UK Research and Innovation invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Seed
- $655k–$4.1M
- Grant
- $109k–$13M
- Pre-Seed
- $62k–$921k
Investment Focus
Industry
- Biotechnology 16 (15%)
- Health Care 15 (14%)
- Education 12 (11%)
- Information Technology 12 (11%)
- Artificial Intelligence 12 (11%)
Stage
- Grant 87 (81%)
- Seed 2 (2%)
- Pre-Seed 2 (2%)
- Venture - Series Unknown 1 (1%)
Country
- United Kingdom 77 (72%)
- United States 4 (4%)
- Canada 2 (2%)
- Pakistan 1 (1%)
- Australia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CEO | Total investments: 1 | Find email | ||
Damien Hatton
Service Design Lead
|
Service Design Lead | Total investments: 0 | Find email | |
Dario Canale
Head of UKRI Creative Services (JRS)
|
Head of UKRI Creative Services (JRS) | Total investments: 0 | Find email | |
Disa Lee Choun
Assessor
|
Assessor | Total investments: 0 | Find email | |
|
George MacGinnis
Healthy Ageing Challenge DirectorHealthy
|
Healthy Ageing Challenge DirectorHealthy | Total investments: 30 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MCatalysis is a deep tech startup developing microwave catalysis technology to convert waste carbon resources such as agricultural residues, plastic waste, and waste gas streams into low-cost, clean synthetic fuels and chemicals at petrochemical cost parity. | $2.3M / Grant / Sep 09, 2026 | ||
| OutSee creates cutting-edge computational methods for genomics for the development of therapeutic targets and precision medicine. | $67.7K / Grant / Sep 08, 2026 | ||
|
Strolll
|
Strolll Neurotechnology | $946.9K / Grant / Sep 03, 2026 | |
| The University of Liverpool is one of the great centres of research, knowledge and innovation. Our pioneering reputation attracts students, experts and partners from around the world. Through our research, teaching and collaborations we seek to be life changing and world shaping.Exceptional minds1,300 leading researchers36,000 students177,000 alumni in 192 countries4,700 staffCountless partners worldwideLiverpool has been home to explorers and revolutionaries for over 800 years. Their pioneering spirit is alive in the city and inspires our university.Our university is everywhere, from our Chinese joint venture University to our Arctic research stations, American exchanges to the Internet home of our online programmes. | $31.9M / Grant / Jun 01, 2026 | ||
| The University of Manchester was formed in 2004 by the amalgamation of the Victoria University of Manchester and the University of Manchester Institute of Science and Technology. It is a member of the worldwide Universities Research Association group, the Russell Group of British research universities and the N8 Group. The University of Manchesterhas been a red brick university since 1880 when Victoria University gained its royal charter.The university owns and operates major cultural assets such as the Manchester Museum, Whitworth Art Gallery, John Rylands Library and Jodrell Bank Observatory. The University of Manchester has 25 Nobel Laureates among its past and present students and staff, the third-highest number of any single university in the United Kingdom after Cambridge and Oxford.According to The Sunday Times, Manchester has a formidable reputation spanning most disciplines, but most notably in the life sciences, engineering, humanities, economics, sociology and the social sciences. The 2013 Times Higher Education World Reputation Rankings have placed Manchester as the 9th most reputable university in Europe. | $4M / Grant / Jan 08, 2026 | ||
| Entos develops next-generation genetic medicines using their proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion. | Grant / Jan 06, 2026 | ||
| Mediphage Bioceuticals is a genetic medicine company focused on developing safe, effective, and personalized transgene delivery platforms for the delivery of genes into cells for gene therapy, cell engineering and gene editing. Our flagship technology, ministring DNA (msDNA) is the safest transgene delivery vector on the market that does notcompromise effectiveness and can be produced at a fraction of the cost of competing solutions. | Grant / Jan 06, 2026 | ||
| Chromatin Bioscience develops synthetic promoter systems by identifying and engineering natural gene regulatory elements using a bioinformatics platform. Its services include designing cell-type-selective promoters for gene and cell therapy, enhancing protein yields in biologics production, and creating tailored promoters for industrial andagricultural biotechnology. The platform integrates algorithmic analysis of genomic data to generate optimized gene expression cassettes for diverse applications. | Grant / Jan 06, 2026 | ||
| KHOTT Biotech is a medical technology company that designs and delivers photodynamic-driven solutions for chronic wound care | $53.9K / Grant / Jan 01, 2026 | ||
| Teesside University is one of the UK’s top institutions of higher education in business. | $1.7M / Grant / Dec 10, 2025 | ||
| See all 107 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does UK Research and Innovation invest in?
UK Research and Innovation invests primarily in Biotechnology, Health Care and Education startups, most often at Grant and Seed stage. Most of the 107 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is UK Research and Innovation's check size?
UK Research and Innovation typically joins rounds of $655k–$4.1M at Seed, $109k–$13M at Grant and $62k–$921k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds UK Research and Innovation participates in.
How do I contact UK Research and Innovation?
Public channels for UK Research and Innovation include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at UK Research and Innovation?
The team at UK Research and Innovation includes Dame Ottoline Leyser (CEO), Damien Hatton (Service Design Lead) and Dario Canale (Head of UKRI Creative Services (JRS)), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
